Bank of New York Mellon Corp boosted its stake in shares of Lemonade, Inc. (NYSE:LMND – Free Report) by 4.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 160,328 shares of the company’s stock after acquiring an additional 6,646 shares during the quarter. Bank of New York Mellon Corp owned 0.22% of Lemonade worth $7,024,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of LMND. SVB Wealth LLC purchased a new position in shares of Lemonade during the 1st quarter valued at approximately $26,000. NewEdge Advisors LLC acquired a new stake in Lemonade during the first quarter valued at $35,000. State of Wyoming purchased a new position in Lemonade in the first quarter valued at $49,000. Caitong International Asset Management Co. Ltd raised its position in shares of Lemonade by 1,008.9% in the second quarter. Caitong International Asset Management Co. Ltd now owns 1,364 shares of the company’s stock worth $60,000 after acquiring an additional 1,241 shares during the period. Finally, Trifecta Capital Advisors LLC purchased a new stake in shares of Lemonade during the 2nd quarter worth about $61,000. Hedge funds and other institutional investors own 80.30% of the company’s stock.
Insiders Place Their Bets
In other news, COO Adina Eckstein sold 40,000 shares of Lemonade stock in a transaction on Friday, November 7th. The stock was sold at an average price of $73.02, for a total transaction of $2,920,800.00. Following the transaction, the chief operating officer owned 227,987 shares in the company, valued at $16,647,610.74. The trade was a 14.93% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John Sheldon Peters sold 2,718 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $50.34, for a total transaction of $136,824.12. Following the transaction, the insider directly owned 102,397 shares in the company, valued at approximately $5,154,664.98. The trade was a 2.59% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 48,988 shares of company stock worth $3,538,884 in the last three months. 14.70% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
View Our Latest Report on Lemonade
Lemonade Stock Down 1.0%
Shares of LMND opened at $67.29 on Friday. The firm’s fifty day moving average is $59.29 and its two-hundred day moving average is $48.39. The stock has a market cap of $5.03 billion, a PE ratio of -28.15 and a beta of 2.27. Lemonade, Inc. has a 52-week low of $24.31 and a 52-week high of $83.77.
Lemonade (NYSE:LMND – Get Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.51) earnings per share for the quarter, topping the consensus estimate of ($0.72) by $0.21. The firm had revenue of $194.50 million for the quarter, compared to the consensus estimate of $185.06 million. Lemonade had a negative net margin of 26.39% and a negative return on equity of 31.86%. The company’s revenue for the quarter was up 42.4% on a year-over-year basis. During the same period last year, the firm posted ($0.95) earnings per share. Lemonade has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, research analysts anticipate that Lemonade, Inc. will post -3.03 earnings per share for the current year.
Lemonade Company Profile
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Featured Articles
- Five stocks we like better than Lemonade
- Health Care Stocks Explained: Why You Might Want to Invest
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
- What is Forex and How Does it Work?
- Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?
Want to see what other hedge funds are holding LMND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lemonade, Inc. (NYSE:LMND – Free Report).
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.
